Friday, 4 October 2013

The controversy over "counterfeit" drugs

lead photo
LONDON, 2 October 2013 (IRIN) - One of the biggest hurdles to stemming the global tide of counterfeit medicines is disagreement over the term itself, which drug companies are accused of hijacking for commercial rather than public health reasons.
Read report online

No comments:

Post a Comment